Fidelity Investments’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.87M Buy
567,032
+180,948
+47% +$2.88M ﹤0.01% 2127
2025
Q4
$6.27M Buy
386,084
+61,588
+19% +$1.01M ﹤0.01% 2206
2025
Q3
$4.85M Buy
324,496
+33,388
+11% +$407K ﹤0.01% 2251
2025
Q2
$3.39M Buy
291,108
+2,641
+0.9% +$24K ﹤0.01% 2301
2025
Q1
$2.14M Buy
288,467
+32,729
+13% +$252K ﹤0.01% 2422
2024
Q4
$1.53M Buy
255,738
+22,172
+9% +$122K ﹤0.01% 2527
2024
Q3
$1.2M Buy
233,566
+117,965
+102% +$514K ﹤0.01% 2546
2024
Q2
$418K Buy
115,601
+9,424
+9% +$29.9K ﹤0.01% 2792
2024
Q1
$341K Sell
106,177
-16
-0% -$62 ﹤0.01% 2845
2023
Q4
$520K Sell
106,193
-12,107
-10% -$55.2K ﹤0.01% 2676
2023
Q3
$645K Buy
118,300
+5,281
+5% +$34.9K ﹤0.01% 2567
2023
Q2
$758K Buy
113,019
+21,835
+24% +$162K ﹤0.01% 2545
2023
Q1
$805K Buy
91,184
+60
+0.1% +$529 ﹤0.01% 2565
2022
Q4
$696K Buy
91,124
+4,012
+5% +$31.2K ﹤0.01% 2630
2022
Q3
$620K Buy
87,112
+74,621
+597% +$703K ﹤0.01% 2720
2022
Q2
$101K Buy
12,491
+6,301
+102% +$55.4K ﹤0.01% 3324
2022
Q1
$86K Sell
6,190
-1,138,262
-99% -$17.9M ﹤0.01% 3496
2021
Q4
$32.1M Buy
1,144,452
+1,143,169
+89,101% +$35M ﹤0.01% 1598
2021
Q3
$44K Sell
1,283
-26,184
-95% -$947K ﹤0.01% 3240
2021
Q2
$1.12M Sell
27,467
-317,656
-92% -$12.3M ﹤0.01% 2644
2021
Q1
$13.9M Sell
345,123
-1,656,127
-83% -$89.6M ﹤0.01% 1926
2020
Q4
$118M Buy
2,001,250
+1,022,838
+105% +$52.7M 0.01% 955
2020
Q3
$47.6M Buy
978,412
+603,311
+161% +$25.4M ﹤0.01% 1213
2020
Q2
$18.1M Sell
375,101
-87,080
-19% -$3.17M ﹤0.01% 1590
2020
Q1
$12.8M Sell
462,181
-55,048
-11% -$1.54M ﹤0.01% 1604
2019
Q4
$15.5M Buy
517,229
+30,426
+6% +$874K ﹤0.01% 1695
2019
Q3
$15M Sell
486,803
-119,597
-20% -$4.88M ﹤0.01% 1683
2019
Q2
$29.3M Buy
+606,400
New +$26.9M ﹤0.01% 1462

Other funds holding ADPT